Leerink Swann Upgrades IDEXX Laboratories (IDXX) to Outperform; Recovering Vet Market
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $550.96 -2.82%
Rating Summary:
13 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Swann upgraded IDEXX Laboratories (NASDAQ: IDXX) from Market Perform to Outperform with a price target raised from $90 to $106.
Analyst, Rick Wise, said, "Driving our positive stance on IDXX: (1) a unique franchise—with very strong market shares, (2) a possibly recovering economy and vet market, (3) a strong track record of innovation, (4) outstanding management team—steered IDXX through growth even in a declining vet market, (5) top-notch return profile —with ROIC at ~22%---among the strongest in our universe, and a track record of consistent share repurchases."
Raises FY12 EPS estimates from $3.10 to $3.12 and FY13 from $3.52 to $3.54.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $86.44 yesterday.
Analyst, Rick Wise, said, "Driving our positive stance on IDXX: (1) a unique franchise—with very strong market shares, (2) a possibly recovering economy and vet market, (3) a strong track record of innovation, (4) outstanding management team—steered IDXX through growth even in a declining vet market, (5) top-notch return profile —with ROIC at ~22%---among the strongest in our universe, and a track record of consistent share repurchases."
Raises FY12 EPS estimates from $3.10 to $3.12 and FY13 from $3.52 to $3.54.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $86.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
